IMNM – immunome, inc. (US:NASDAQ)

News

Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Immunome to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026 [Yahoo! Finance]
Immunome to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026
Immunome (NASDAQ:IMNM) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Immunome (IMNM) Is Up 11.7% After Phase 3 Varegacestat Success - Has The Bull Case Changed? [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com